Verdad Advisers’s Colgate-Palmolive CL Stock Holding History

Verdad Advisers’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-37,500	Closed	-$2.95M	–	41
2022 Q4	$2.95M	Sell	37,500 -10,500	-22%	-$787K	2.98%	5
2022 Q3	$3.37M	Hold	48,000	–	–	4.9%	5
2022 Q2	$3.85M	Hold	48,000	–	–	3.63%	5
2022 Q1	$3.64M	Buy	48,000 +4,000	+9%	+$317K	2.98%	15
2021 Q4	$3.75M	Buy	44,000 +20,000	+83%	+$1.56M	2.54%	9
2021 Q3	$1.81M	Buy	+24,000	New	+$1.91M	1.31%	24

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Verdad Advisers's CL Position: Q1 2023 in Review

Verdad Advisers sold out of Colgate-Palmolive (CL) in Q1 2023, closing a stake of 37,500 shares — an estimated $2.95M sold.

Verdad Advisers first reported a position in CL in Q3 2021 and held it in 6 quarters. The position peaked at $3.85M in Q2 2022. 1,657 funds tracked by Wall St. Rank hold CL as of Q1 2023.

Verdad Advisers reported no remaining Colgate-Palmolive position as of Q1 2023 after selling out during the quarter.
Verdad Advisers sold 37,500 Colgate-Palmolive shares in Q1 2023, an estimated $2.95M.
Verdad Advisers first reported a position in Colgate-Palmolive in Q3 2021 and held it in 6 quarters.
Verdad Advisers's Colgate-Palmolive position peaked at $3.85M in Q2 2022.
1,657 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2023.

Based on Verdad Advisers's 13F filing for Q1 2023, filed 12 May 2023.